Skip to main content
. 2021 Jun 4;11(15):7589–7599. doi: 10.7150/thno.61259

Figure 2.

Figure 2

In vitro assessment of CANS, RBC/CANS, and PLT/CANS. A) Cell viability of RAW 264.7 cells treated with the indicated nanoparticle doses. B) Au levels in CT 26 cells treated with the indicated nanoparticle doses. C) Fluorescence images of CT 26 cells treated with Cy5-labeled RBC/CANS or PLT/CANS (50 μg/mL). Scale bars: 50 μm. D) Cell viability of CT 26 cells incubated with the indicated nanoparticle doses and then irradiated with 6 Gy. E) Results of a colony formation assay assessing treatment outcomes at a range of radiation doses. F) Images of a colony formation assay at a radiation dose of 6 Gy. ** P < 0.01; *** P < 0.001.